Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
KALV
KALV
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
KALV News
KalVista Reports Interim Results of EKTERLY Clinical Trial
Mar 30 2026
NASDAQ.COM
KALVISTA PHARMACEUTICALS INC - INITIAL DATA INDICATES SEBETRALSTAT PROVIDES PROMPT AND EFFICIENT TREATMENT FOR HAE IN CHILDREN
Mar 30 2026
moomoo
KALVISTA PHARMACEUTICALS INC: STIFEL INCREASES TARGET PRICE FROM $39 TO $42
Mar 26 2026
moomoo
KalVista Pharmaceuticals Reports 2025 Fiscal Year Performance
Mar 25 2026
Yahoo Finance
KalVista Reports $49.1 Million Revenue for EKTERLY® in Eight Months
Mar 25 2026
Newsfilter
KALVISTA PHARMACEUTICALS INC - ANNOUNCES EPS OF $-2.03 FOR THE EIGHT-MONTH PERIOD ENDING DECEMBER 31, 2025
Mar 25 2026
moomoo
KalVista Pharmaceuticals Q4 Earnings Beat Expectations
Mar 25 2026
seekingalpha
KALVISTA PHARMACEUTICALS INC REPORTS $49.1 MILLION IN NET PRODUCT REVENUE FOR THE EIGHT-MONTH PERIOD ENDING DECEMBER 31, 2025
Mar 25 2026
moomoo
KalVista Pharmaceuticals Set to Announce Q4 Earnings on March 25
Mar 24 2026
seekingalpha
KalVista Presents New Data at Global Conference
Mar 20 2026
Newsfilter
VR Adviser, LLC Reduces Stake in Ocular Therapeutix
Mar 18 2026
Fool
VR Adviser, LLC Sells Shares of Ocular Therapeutix
Mar 18 2026
NASDAQ.COM
KalVista Pharmaceuticals to Host Financial Results Conference Call
Mar 18 2026
Newsfilter
VR Adviser Increases Stake in Savara by Over 1 Million Shares
Mar 15 2026
NASDAQ.COM
VR Adviser Increases Stake in Savara by Over 1 Million Shares
Mar 15 2026
Fool
Needham Raises Kalvista Price Target to $35
Jan 09 2026
Benzinga
Show More News
